Stocktoria

EXOZYMES INC. EXOZ

Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2024-11-13

EXOZYMES INC. statistics & valuation

Market cap$72.8M
P / B21.4×
Return on capital-220.6%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
202320242025
Operating margin (%)
-2563.50% 202320242025
Return on equity (%)
-56.20% -269.60% 202320242025
Shares outstanding
6.3M 8.4M 8.4M 202320242025
Net debt ($)
202320242025
Share buybacks ($)
202320242025
Return on assets (%)
-57.30% -45.00% -153.40% 202320242025
Free cash flow margin (%)
-2097.30% 202320242025
Debt / equity (×)
202320242025
EPS ($)
-$0.33 -$0.89 -$1.09 202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023
Operating margin——-2563.5%
Net margin——-2909.1%
FCF margin——-2097.3%
Return on assets-153.4%-45.0%-57.3%
Return on equity-269.6%-56.2%530.4%
Current ratio2.518.120.50

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.